Qualigen Therapeutics appoints Kevin Chen as independent director
PositiveFinancial Markets

Qualigen Therapeutics has appointed Kevin Chen as an independent director, a move that signals the company's commitment to strengthening its leadership team. Chen's extensive experience in the biotech industry is expected to bring valuable insights and guidance as Qualigen continues to innovate and expand its portfolio. This appointment is significant as it reflects the company's strategic efforts to enhance its governance and drive future growth.
— Curated by the World Pulse Now AI Editorial System